Everything you need to know about Aktis Oncology’s upcoming IPO

[ad_1] IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year’s sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the latest biotech firm to pursue an initial public offering.…